Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
Grivas, Petros, Kopyltsov, Evgeny, Su, Po-Jung, Parnis, Francis X., Park, Se Hoon, Yamamoto, Yoshiaki, Fong, Peter C., Tournigand, Christophe, Climent Duran, Miguel A., Bamias, Aristotelis, Caserta, Claudia, Chang, Jane, Cislo, Paul, di Pietro, Alessandra, Wang, Jing, Powles, Thomas
Published in European urology (01.04.2023)
Published in European urology (01.04.2023)
Get full text
Journal Article
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study
Wheatley, Duncan A., Berardi, Rossana, Climent Duran, Miguel A., Tomiak, Anna, Greystoke, Alastair P., Joshua, Anthony M., Arkenau, Hendrik-Tobias, Géczi, Lajos, Corbacho, Javier Garciá, Paz-Ares, Luis G., Hussain, Syed A., Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C., Michelon, Elisabete, Murphy, Danielle A., Mwewa, Sandrine, Cesari, Rossano, Doger de Spéville, Bernard
Published in Cancer research communications (28.06.2024)
Published in Cancer research communications (28.06.2024)
Get full text
Journal Article
Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database
Hassi Roman, Mario, Mate, Kinga, De Pablos-Rodriguez, Pedro, Horcajada, Álvaro Zamora, Cascales, Ana Guijarro, Bonet, Ángeles Sanchís, Vilaseca, Antoni, Vázquez-Martul Pazos, Darío, Espinós, Estefanía Linares, Rodríguez, Jesús Muñoz, de la Morena Gallego, José Manuel, Alemán, José Ramón, Rivas, Juan Gómez, Formisano, Luigi, Juan Fita, Maria J., Planells, Marc Costa, Esteban, Mario Domínguez, Márquez, Meritxell Pérez, Sanz, Miguel García, Expósito, Nagore García, Picola, Natalia, Vives, Pol Servian, Sutil, Raquel Sopeña, Climent Durán, Miguel A., Backhaus, Miguel Ramírez
Published in European urology open science (Online) (01.12.2024)
Published in European urology open science (Online) (01.12.2024)
Get full text
Journal Article
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance
Sridhar, Srikala S., Powles, Thomas, Climent Durán, Miguel Á., Park, Se Hoon, Massari, Francesco, Thiery-Vuillemin, Antoine, Valderrama, Begoña P., Ullén, Anders, Tsuchiya, Norihiko, Aragon-Ching, Jeanny B., Gupta, Shilpa, Petrylak, Daniel P., Bellmunt, Joaquim, Wang, Jing, Laliberte, Robert J., di Pietro, Alessandra, Costa, Nuno, Grivas, Petros, Sternberg, Cora N., Loriot, Yohann
Published in European urology (01.02.2024)
Published in European urology (01.02.2024)
Get full text
Journal Article
Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial
Bellmunt, Joaquim, Necchi, Andrea, De Wit, Ronald, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J., Climent Durán, Miguel A., Petrylak, Daniel P., Choueiri, Toni K., Gerritsen, Winald R., Gurney, Howard, Quinn, David I., Culine, Stephane, Sternberg, Cora N., Xu, Jin Zhi, Homet Moreno, Blanca, Godwin, James Luke, Bajorin, Dean F., Vaughn, David J., Fradet, Yves
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY
Sridhar, Srikala S., Powles, Thomas, Gupta, Shilpa, Climent Duran, Miguel A., Aragon-Ching, Jeanny B., Sternberg, Cora N., Cislo, Paul, Costa, Nuno, di Pietro, Alessandra, Bellmunt, Joaquim, Grivas, Petros
Published in The Journal of urology (01.05.2024)
Published in The Journal of urology (01.05.2024)
Get full text
Journal Article
Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden
Bellmunt, Joaquim, Powles, Thomas, Park, Se Hoon, Voog, Eric, Valderrama, Begoña Pérez, Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S., Tsuchiya, Norihiko, Sternberg, Cora N., Aragon-Ching, Jeanny B., Petrylak, Daniel P., Climent Duran, Miguel A., Tyroller, Karin, Hoffman, Jason, Jacob, Natalia, Grivas, Petros, Gupta, Shilpa
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study
López-Abad, Alicia, Ramírez Backhaus, Miguel, Server Gómez, Gerardo, Cao Avellaneda, Enrique, Moreno Alarcón, Cristóbal, López Cubillana, Pedro, Yago Giménez, Pablo, de Pablos Rodríguez, Pedro, Juan Fita, María J., Climent Durán, Miguel Á., Guardiola Ruiz, Iris, Vidal Crespo, Natalia, Artés Artés, Miriam, Montoya Chinchilla, Raúl, Moreno Avilés, Juan, Guzmán Martínez-Valls, Pablo L., López González, Pedro Á.
Published in Prostate international (01.03.2024)
Published in Prostate international (01.03.2024)
Get full text
Journal Article
First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study
Lee, Chung-Han, Gurney, Howard, Atduev, Vagif, Suárez, Cristina, Climent Duran, Miguel A, Pook, David William, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae-Lyun, Nalbandian, Taron, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Burgents, Joseph, Sharma, Manish, Peng, Xiang, Albiges, Laurence
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study
Wheatley, Duncan A, Berardi, Rossana, Climent Duran, Miguel A, Tomiak, Anna, Greystoke, Alastair P, Joshua, Anthony M, Arkenau, Hendrik-Tobias, Géczi, Lajos, Garcia-Corbacho, Javier, Paz-Ares, Luis G, Hussain, Syed A, Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C, Michelon, Elisabete, Murphy, Danielle A, Mwewa, Sandrine, Cesari, Rossano, Doger de Speville, Bernard
Published in Cancer research communications (26.04.2024)
Get full text
Published in Cancer research communications (26.04.2024)
Journal Article
Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study
Castellano, Daniel E., Duran, Ignacio, Mellado, Begona, Climent Duran, Miguel Angel A., Garcia del Muro, Xavier, Sala González, Nuria, Alonso Gordoa, Teresa, Sevillano, Elena, Domenech, Montserrat, Paramio, Jesus, Real, Francisco X., Malats, Nuria, Sanz, Juan Luis, Font, Albert
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study
Climent Duran, Miguel Angel A., Perez-Gracia, Jose Luis, Arranz Arija, Jose Angel, Alvarez-Fernandez, Carlos, Gomez Mediavilla, Jenifer, Rodriguez, Angel, Vazquez-Estevez, Sergio, Jurado, Jose Miguel, Santander, Carmen, Bonfill, Teresa, Molins Palau, Carmen, Perez Ramirez, Sara, Pimentel Cáceres, Paola, Arnáiz, Pablo, Garate, Zita, Soto, Atenea, Puente, Javier
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
A phase 2 study of the efficacy and safety of INCMGA00012 in advanced penile squamous cell carcinoma (PSqCC): ORPHEUS
Garcia del Muro, Xavier, Riva, François, Cuellar, M. Andres, Maroto-Rey, Pablo, Castellano, Daniel E., Giannatempo, Patrizia, Climent Duran, Miguel Angel A., Necchi, Andrea, Pérez-Valderrama, Begoña, Gomez De Liano Lista, Alfonso, Garcias-Espana, Carmen, Puente, Javier, Ros, Silverio, Santander, Carmen, Masini, Cristina, Martínez de Falcon, Marta, Garcia, Almudena, Sampayo-Cordero, Miguel, Malfettone, Andrea, Paez, David
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST
Mateo, Joaquin, Borque, Ángel, Castellano, Daniel E., Castro, Elena, Climent Duran, Miguel Angel A., Font, Albert, Lorente, David, Mellado, Begona, Rodriguez-Vida, Alejo, Cuadras, Merce, Planas, Jacques, Casanova Salas, Irene, Cordoba, Sarai, Gonzalez, Lucila, Martínez de Falcon, Marta, Fernández, Melissa, Sampayo-Cordero, Miguel, Malfettone, Andrea, Perez-Lopez, Raquel, Carles, Joan
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial
Roubaud, Guilhem, Kostine, Marie, McDermott, Raymond S., Bernard-Tessier, Alice, Maldonado, Xavier, Silva, Marlon, Flechon, Aude, Berthold, Dominik R., Ronchin, Philippe, Tombal, Bertrand F., Mourey, Loic, Gravis, Gwenaelle, Escande, Anne, Abadie Lacourtoisie, Sophie, Thiery-Vuillemin, Antoine, Climent Duran, Miguel Angel A., Ribault, Hélène, Bossi, Alberto, Foulon, Stéphanie, Fizazi, Karim
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE
Sridhar, Srikala S., Powles, Thomas, Loriot, Yohann, Climent Durán, Miguel A., Gupta, Shilpa, Tsuchiya, Norihiko, Bamias, Aristotelis, Ardizzoni, Andrea, Ullén, Anders, Huang, Bo, Costa, Nuno, Laliberte, Robert J, di Pietro, Alessandra, Sternberg, Cora N, Grivas, Petros
Published in The Journal of urology (01.09.2021)
Published in The Journal of urology (01.09.2021)
Get full text
Journal Article
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance
Sridhar, Srikala S., Powles, Thomas, Loriot, Yohann, Climent Durán, Miguel A., Gupta, Shilpa, Tsuchiya, Norihiko, Bamias, Aristotelis, Ardizzoni, Andrea, Ullén, Anders, Huang, Bo, Costa, Nuno Matos, Laliberte, Robert J, Di Pietro, Alessandra, Sternberg, Cora N., Grivas, Petros
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Neoadjuvant and adjuvant chemotherapy in bladder cancer
Durán, Miguel A. Climent, Porta, Vicente Guillem
Published in Revista de oncología (Barcelona, Spain) (01.09.2000)
Published in Revista de oncología (Barcelona, Spain) (01.09.2000)
Get full text
Journal Article